Iskandar Malaysia
Biocon India’s chairman bullish on Malaysia’s biotech prospects
The chairman and founder of India’s largest biotech company sees a bright future for Malaysia’s biotech ambitions, but notes that the lack of sufficient highly skilled talent could derail ambitions.
Where the action is clearly down south
Iskandar Malaysia made great progress in getting investors, both foreign and local, to buy into its growth story. However, Malaysians remain skeptical about the mega project.
Iskandar likely to cross RM100bil investment mark by year end
The momentum that the Iskandar Malaysia development hub is experiencing can be seen in the numbers: From an average investment of between RM8 billion and RM10 billion from 2006 to 2009, rising to between RM12 billion and RM15 billion in 2010-2011, this year will see the committed investment hit RM20 billion says an excited Datuk Ismail Ibrahim, chief executive officer of the Iskandar Regional Development Authority or IRDA.
Frost & Sullivan’s game changer bet on Iskandar Malaysia
Frost & Sullivan expects to invest an estimated US$176 million into its Global Innovation Center in the Iskandar Malaysia development hub by 2020. Its global president and managing partner Aroop Zutshi talks to DNA founder Karamjit Singh on the reasons he believes that the development of the GIC will be a real game-changer for the future of the company. [Video included].
Bio-XCell taking shape in Iskandar
With great power comes great responsibility. For Rizatuddin Ramli, the boyish-faced chief executive officer of Malaysian Bio-XCell Sdn Bhd, one can say, with great investment, comes great expectations.
